Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 35Breast Neoplasms 8Obesity 5Neoplasms 5Prostatic Neoplasms 4Insulin Resistance 4Pancreatic Neoplasms 3Infertility 3Endometrial Neoplasms 3Diabetes Mellitus 3Triple Negative Breast Neoplasms 2Neuroendocrine Tumors 2Mouth Neoplasms 2Metabolic Syndrome 2Liver Neoplasms 2Hyperandrogenism 2Diabetes, Gestational 2Diabetes Mellitus, Type 2 2Depression 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Anovulation 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1

Interventions

Docetaxel 5Pemetrexed 4Capecitabine 4pembrolizumab 3Oxaliplatin 3icotinib 2Radiation 2Paclitaxel 2Gemcitabine 2Gefitinib 2Fluorouracil 2Drug Therapy 2Chemoradiotherapy 2Carboplatin 2sintilimab 1rucaparib 1regorafenib 1olaparib 1lenvatinib 1iron isomaltoside 1000 1ipatasertib 1iopromide 1gluconic acid 1elemene 1capecitabine-irinotecan combination 1aumolertinib 1atezolizumab 1anlotinib 1aflutinib 1XELOX 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma × Metformin × Clear all
NCT01930864 2017-06-22

Metformin Plus Irinotecan for Refractory Colorectal Cancer

Barretos Cancer Hospital

Phase 2 Unknown
41 enrolled
Gastrointestinal

Adenocarcinoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡